• Mashup Score: 0

    On this episode of Managed Care Cast, Ryan Haumschild, PharmD, MS, MBA, from Emory Healthcare and the Winship Cancer Institute, explains the evolution of biosimilar pharmacoeconomics and the different strategies that health care institutions can implement to reap the benefits of biosimilar savings.

    Tweet Tweets with this article
    • ICYMI: On the latest episode of #ManagedCareCast, @Rxhaums (@emoryhealthcare, @WinshipAtEmory) explains the evolution of #biosimilar pharmacoeconomics & different strategies #healthcare institutions can implement to reap benefits of biosimilar savings. https://t.co/mVT3tGyGwy https://t.co/a63IVz5ZV8

  • Mashup Score: 0

    On this episode of Managed Care Cast, we speak with the author of an article in the August issue of The American Journal of Managed Care® about the premium tax credits for health insurance purchased through the health care marketplace, which were recently extended for another 2 years with the signing of the Inflation Reduction Act.

    Tweet Tweets with this article
    • On this episode of #ManagedCareCast, we speak with the author of an article in our August issue about premium tax credits for health insurance purchased through the #healthcare marketplace, which were recently extended under the Inflation Reduction Act. https://t.co/rzvDvXqosD https://t.co/Ggm4fh8cWV

  • Mashup Score: 1

    How much would have Medicare saved if it had the same ability to purchase generic drugs at the same price as individuals using direct-to-consumer (DTC) pharmacies like the Mark Cuban Cost Plus Drug Company? Billions, as it turns out.

    Tweet Tweets with this article
    • Have you listened to this week's #ManagedCareCast? 🎧 We spoke with @DrHussainL, coauthor of an analysis that found #Medicare could have saved up to $3.6 billion in 2020 if it bought 77 generic drugs at @costplusdrugs 2022 prices. Listen here! https://t.co/5Zc81kFjIX https://t.co/iUDfHFzIiX

  • Mashup Score: 0

    This episode of Managed Care Cast features interviews with experts who discuss how the same efforts to stamp out COVID-19 also reduced Clostridioides difficile and the prospects for such mitigation efforts to continue.

    Tweet Tweets with this article
    • Have you listened to the latest episode of #ManagedCareCast? On this episode, experts discuss how the same efforts to stamp out #COVID19 also reduced Clostridium difficile. They expand on the prospects for such mitigation efforts to continue–Listen here! https://t.co/W7M0DHdzPX https://t.co/6UrZciC19p